Latest HUYA Bioscience International Stories
Second cohort underway in non-Hodgkin's lymphoma patients SAN DIEGO, March 19, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) has completed the first cohort in a Phase 1
Appoints Alain Rolland, Pharm.D., Ph.D., as Executive Vice President and Chief Scientific Officer SAN DIEGO, March 12, 2015 /PRNewswire/ -- HUYA Bioscience International (HUYA) today
HUYA holds exclusive rights to chidamide as HBI-8000 ex-China SAN DIEGO, Jan.
SAN DIEGO, Dec.
SAN DIEGO, Sept.
SAN DIEGO, Aug.